Best Testicular Cancer Doctors in Hyderabad — CION's Dedicated Testicular Cancer Panel

The best doctor for testicular cancer is a surgical oncologist or uro-oncologist with experience in radical inguinal orchidectomy and RPLND, paired with a medical oncologist current with BEP chemotherapy and a radiation oncologist for selected seminoma cases. At CION, every testicular cancer case is reviewed by a multidisciplinary tumour board, with surgical leadership by Dr. Raghavendra Naik (M.Ch Surgical Oncology, SVIMS Tirupati) and medical oncology by Dr. C. Raghavendra Reddy (DM Medical Oncology, Gold Medal).

Yes — sperm banking before treatment is the standard of care for testicular cancer patients of reproductive age. Both surgery (orchidectomy of one testicle) and especially chemotherapy with BEP regimen can affect fertility, though the remaining testicle typically compensates after surgery. Sperm cryopreservation provides insurance for future fertility regardless. This should happen before orchidectomy where possible, and certainly before chemotherapy. CION coordinates sperm banking with accredited reproductive medicine partners in Hyderabad. The fertility conversation is part of the first consultation, not raised later.

This is the critical pathology distinction. Seminoma (about 50% of testicular germ cell tumours) is slower-growing and highly sensitive to both chemotherapy and radiation; it tends to occur in men in their 30s–40s and remain localised longer. Non-seminoma (the other 50%) is generally more aggressive, spreads earlier, but is equally curable with BEP chemotherapy; it does not respond well to radiation. Treatment differs substantially — radiation is an option for Stage IIA–IIB seminoma but not for non-seminoma; surveillance after orchidectomy is offered for Stage I seminoma differently than for Stage I non-seminoma; RPLND is more often used for non-seminoma. The first job of the pathologist and tumour board is to confirm which subtype you have.

BEP is the standard chemotherapy regimen for testicular cancer — bleomycin, etoposide, and cisplatin. It is given in 21-day cycles, typically 3–4 cycles depending on stage and risk classification. BEP has one of the highest cure rates of any chemotherapy regimen in oncology — over 90% for good-risk metastatic disease. Side effects include nausea, fatigue, hair loss, neuropathy, lung toxicity from bleomycin, and effects on hearing and kidneys from cisplatin. CION's medical oncology team delivers BEP with appropriate supportive care to manage these side effects.

RPLND (retroperitoneal lymph node dissection) is a complex surgery that removes lymph nodes in the back of the abdomen — the primary site of spread for testicular cancer. It is used for: (1) Stage I non-seminoma in patients who choose surgery over surveillance, (2) Stage II non-seminoma after chemotherapy if residual nodes remain, and (3) selected post-chemotherapy residual masses. RPLND requires onco-surgical training; CION's surgical oncology team performs RPLND directly. Modern techniques (nerve-sparing RPLND) can preserve ejaculatory function in most appropriately selected cases.

Active surveillance is a strategy where, after orchidectomy of the affected testicle, patients with Stage I disease (no spread) are monitored closely with regular tumour markers (AFP, beta-HCG, LDH), imaging, and physical examination — rather than receiving immediate chemotherapy or radiation. About 80% of Stage I patients are cured by orchidectomy alone; the 20% who recur are caught early and still cured with chemotherapy. Active surveillance avoids unnecessary chemotherapy in the majority of patients while preserving cure rates. It requires committed follow-up. CION offers active surveillance as a Stage I option.

Yes — testicular cancer is one of the few cancers with reliable blood-based tumour markers that guide diagnosis, staging, prognosis, and follow-up: AFP (alpha-fetoprotein) — elevated in non-seminoma, never in pure seminoma; Beta-HCG (human chorionic gonadotropin) — can be elevated in both seminoma and non-seminoma; LDH (lactate dehydrogenase) — non-specific marker correlating with tumour bulk. Markers are drawn before surgery, after surgery (to assess clearance), during chemotherapy (to assess response), and during follow-up (to detect recurrence). CION's pathway includes serial marker monitoring at every visit.

After radical inguinal orchidectomy, one testicle is removed. For cosmetic concerns, a testicular prosthesis (implanted at the time of surgery or later) is available — discuss this with your surgeon. The remaining testicle usually compensates for hormone and sperm production over time. Most men have normal testosterone levels, normal sexual function, and (with banked sperm) fertility options. The visible difference is the surgical scar in the groin (inguinal incision) and the absence of one testicle in the scrotum — both addressed by prosthesis if desired.

A second opinion is valuable for testicular cancer — particularly because the choice between active surveillance, RPLND, and chemotherapy for Stage I–II disease varies across centres, and because sperm banking may not be discussed at every centre. At CION the second opinion is free, written, and yours to keep — our multidisciplinary tumour board reviews your pathology, imaging, and markers and provides a documented opinion you can take anywhere.

Costs vary by stage and treatment. Radical inguinal orchidectomy ranges approximately ₹80,000 to ₹2,00,000; BEP chemotherapy (3–4 cycles) ranges ₹1,50,000 to ₹4,00,000; RPLND ranges ₹2,00,000 to ₹4,50,000; radiation therapy for seminoma ranges ₹2,00,000 to ₹4,00,000. Sperm banking is typically ₹15,000 to ₹30,000 for collection plus annual storage fees. For a detailed cost breakdown, see our testicular cancer treatment in Hyderabad page. Every CION patient receives a written, itemised cost estimate before treatment begins. Aarogyasri, EMI, and cashless insurance are accepted.